Sulfonamides (Trimethoprim-Sulfamethoxazole / TMP-SMX)

This note reviews trimethoprim-sulfamethoxazole (TMP-SMX), a key sulfonamide combination antibiotic frequently tested on the NCLEX. It covers how the drug works, what it treats, the adverse effects nurses must watch for, and the safety rules that protect patients from serious harm.

Drug Identification

Mechanism of Action

• TMP-SMX inhibits bacterial folic acid synthesis.
• The combination blocks two sequential steps in the bacterial folate pathway.
• This dual action increases antibacterial effectiveness.

Spectrum

• Active against both gram-positive and gram-negative bacteria.
• Important organisms include:
  • Escherichia coli
  • Staphylococcus aureus (including MRSA skin infections)
  • Pneumocystis jirovecii
  • Shigella
• Widely used for urinary tract infections and opportunistic infections.

Indications

• Urinary tract infections (UTIs)
• Pneumocystis pneumonia (PCP) — TMP-SMX is the drug of choice
• MRSA skin infections
• Traveler's diarrhea
• Ear infections (otitis media)

Side Effects

• Common: nausea, vomiting, rash.
• Serious:
  • Stevens-Johnson syndrome
  • Blood dyscrasias
  • Photosensitivity
  • Hemolytic anemia in patients with G6PD deficiency

Labs to Monitor

• CBC — sulfonamides can affect blood cells.
• Renal function — BUN and creatinine.
• Electrolytes, particularly potassium.

Contraindications

• Sulfa allergy
• Severe renal or liver disease
• Use with caution in patients with G6PD deficiency

Pregnancy Safety

• Generally avoided during pregnancy, especially near term.
• Risk of kernicterus in newborns.
• Alternative antibiotics are usually preferred.

Nursing Safety Rules & High-Yield NCLEX Traps

• Encourage adequate fluid intake to prevent kidney complications (including crystalluria).
• Advise patients to avoid excessive sun exposure due to photosensitivity.
• Monitor for rash or severe skin reactions — stop the drug and notify the provider immediately if these occur.
• Common NCLEX traps:
  • Missing a sulfa allergy history before administering.
  • Ignoring severe rash or skin symptoms (possible Stevens-Johnson syndrome).
  • Failing to monitor blood counts during therapy.

Key Takeaways

• TMP-SMX inhibits bacterial folic acid synthesis through a dual-step block of the folate pathway.
• First-line for UTIs and the drug of choice for Pneumocystis pneumonia (PCP).
• Watch for Stevens-Johnson syndrome, blood dyscrasias, photosensitivity, and hemolytic anemia in G6PD deficiency.
• Contraindicated in patients with sulfa allergy and avoided near term in pregnancy due to kernicterus risk.
• Nursing care: push fluids, protect from sun, and monitor CBC and renal function.